
Irish ayes? A new Brexit deal
The Intelligence from The Economist
00:00
Psychedelics in Mental Health Treatment
This chapter examines the rising interest in psychedelics as viable treatments for mental health issues, contrasting their medical research with the cannabis industry. It discusses safety concerns, recent FDA approvals for psilocybin trials, and the potential for new technologies to enhance psychedelic therapies.
Transcript
Play full episode